Keildson, S.* ; Fadista, J.* ; Ladenvall, C.* ; Hedman, A.K.* ; Elgzyri, T.* ; Small, K.S.* ; Grundberg, E.* ; Nica, A.C.* ; Glass, D.* ; Richards, J.B.* ; Barrett, A.* ; Nisbet, J.* ; Zheng, H.F.* ; Rönn, T.* ; Ström, K.* ; Eriksson, K.F.* ; Prokopenko, I.* ; MAGIC Consortium (Grallert, H. ; Gieger, C. ; Thorand, B. ; Meisinger, C. ; Illig, T. ; Wichmann, H.-E.) ; DIAGRAM Consortium (Huth, C. ; Grallert, H. ; Klopp, N. ; Meitinger, T. ; Petersen, A.-K. ; Thorand, B. ; Wichmann, H.-E. ; Illig, T. ; Gieger, C.) ; MuTHER Consortium (*) ; Spector, T.D.* ; Dermitzakis, E.T.* ; Deloukas, P.* ; McCarthy, M.I.* ; Rung, J.* ; Groop, L.* ; Franks, P.W.* ; Lindgren, C.M.* ; Hansson, O.*
Expression of phosphofructokinase in skeletal muscle is influenced by genetic variation and associated with insulin sensitivity.
Diabetes 63, 1154-1165 (2014)
Using an integrative approach where genetic variation, gene expression and clinical phenotypes are assessed in relevant tissues may help functionally characterize the genetic contribution to disease susceptibility. We sought to identify genetic variation influencing skeletal muscle gene expression (eQTL), as well as expression associated with measures of insulin sensitivity. We investigated associations of 3799401 genetic variants with gene expression from >7000 genes from three cohorts (n=104). We identified 287 genes with cis-acting eQTLs (FDR<5%; P<1.96x10(-5)) and 49 expression-insulin sensitivity phenotype associations (i.e. fasting insulin, HOMA-IR and BMI) (FDR<5%; P=1.34x10(-4)). One of these associations, fasting insulin/phosphofructokinase (PFKM), overlaps with an eQTL. Further, the expression of PFKM, a rate-limiting enzyme in glycolysis, was nominally associated with glucose uptake in skeletal muscle (P=0.026, n=42) and over-expressed (PBF-corrected=0.03) in skeletal muscle in T2D patients (n=102) compared with normoglycemic controls (n=87). The PFKM eQTL (rs4547172; PeQTL=7.69x10(-6)) was nominally associated with glucose uptake, glucose oxidation rate, intramuscular triglyceride content, and metabolic flexibility (P=0.016-0.048, n=178). We explored eQTL results using published GWAS data (from DIAGRAM and MAGIC) and a proxy for the PFKM eQTL (rs11168327, r2=0.75), was nominally associated with T2D (PDIAGRAM=2.7x10(-3)). Taken together, our analysis highlights PFKM as a potential regulator of skeletal muscle insulin sensitivity.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Polycystic-ovary-syndrome; Fatty-acid-metabolism; Reduced Expression; Glucose-tolerance; Enzyme-activity; Obese Women; In-vivo; Resistance; Transcriptomics; Metaanaly
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2014
Prepublished im Jahr
2013
HGF-Berichtsjahr
2013
ISSN (print) / ISBN
0012-1797
e-ISSN
1939-327X
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 63,
Heft: 3,
Seiten: 1154-1165
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Diabetes Association
Verlagsort
Alexandria, VA.
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30201 - Metabolic Health
30202 - Environmental Health
30503 - Chronic Diseases of the Lung and Allergies
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504100-001
G-521500-002
G-504000-002
G-504200-001
G-503900-001
G-501900-401
G-500700-001
Förderungen
Copyright
Erfassungsdatum
2013-12-09